MUFG Americas’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-80
Closed -$3K 681
2021
Q1
$3K Buy
+80
New +$3.75K ﹤0.01% 661
2017
Q2
Sell
-50
Closed -$2K 1136
2017
Q1
$2K Buy
+50
New +$1.95K ﹤0.01% 1033
2016
Q2
Sell
-34
Closed -$1K 1103
2016
Q1
$1K Sell
34
-2,131
-98% -$56.8K ﹤0.01% 1137
2015
Q4
$72K Sell
2,165
-1,425
-40% -$44.3K ﹤0.01% 538
2015
Q3
$102K Sell
3,590
-8,356
-70% -$291K ﹤0.01% 522
2015
Q2
$484K Sell
11,946
-2,875
-19% -$129K 0.02% 378
2015
Q1
$729K Sell
14,821
-5,777
-28% -$268K 0.02% 326
2014
Q4
$937K Buy
+20,598
New +$809K 0.03% 296

Other funds holding AVNS

MUFG Americas's AVNS Position: Q2 2021 in Review

MUFG Americas sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 80 shares — an estimated $3K sold.

MUFG Americas first reported a position in AVNS in Q4 2014 and held it in 8 quarters. The position peaked at $937K in Q4 2014. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • MUFG Americas reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • MUFG Americas sold 80 Avanos Medical shares in Q2 2021, an estimated $3K.
  • MUFG Americas first reported a position in Avanos Medical in Q4 2014 and held it in 8 quarters.
  • MUFG Americas's Avanos Medical position peaked at $937K in Q4 2014.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on MUFG Americas's 13F filing for Q2 2021, filed 6 Aug 2021.